These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33542038)

  • 1. Equity considerations in outcome measures of the HIV pre-exposure prophylaxis care continuum in high-income countries: a systematic review protocol.
    Cabecinha M; Solomon D; Rait G; Saunders J; Mohammed H; McDonagh LK
    BMJ Open; 2021 Feb; 11(2):e040701. PubMed ID: 33542038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Exposure Prophylaxis Care Continuum for HIV Risk Populations: An Umbrella Review of Systematic Reviews and Meta-Analyses.
    Jin G; Shi H; Du J; Guo H; Yuan G; Yang H; Zhu Z; Zhang J; Zhang K; Zhang X; Lu X; Xu W; Wang S; Hao J; Sun Y; Su P; Zhang Z
    AIDS Patient Care STDS; 2023 Dec; 37(12):583-615. PubMed ID: 38011347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexually transmitted infections among high-risk populations that use treatment as prevention or pre-exposure prophylaxis: a protocol for a systematic review.
    Coudray M; Kiplagat S; Saumell F; Madhivanan P
    BMJ Open; 2019 Dec; 9(12):e032054. PubMed ID: 31811008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of HIV pre-exposure prophylaxis (PrEP) programmes by delivery models in the Asia-Pacific through the healthcare accessibility framework.
    Lau JY; Hung CT; Lee SS
    J Int AIDS Soc; 2020 Jul; 23(7):e25531. PubMed ID: 32603517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Structural Racism and Discrimination Along the Pre-exposure Prophylaxis Continuum: A Systematic Review.
    Seyedroudbari S; Ghadimi F; Grady G; Uzosike O; Nkwihoreze H; Jemmott JB; Momplaisir F
    AIDS Behav; 2024 Sep; 28(9):3001-3037. PubMed ID: 38851649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences for pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women at risk of HIV infection: a multicentre protocol for a discrete choice experiment in Brazil.
    Pereira CCA; Torres TS; Luz PM; Hoagland B; Farias A; Brito JDU; Guimarães Lacerda MV; da Silva DAR; Benedetti M; Pimenta MC; Grinsztejn B; Veloso VG
    BMJ Open; 2021 Sep; 11(9):e049011. PubMed ID: 34580095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology-Based Interventions to Promote the HIV Preexposure Prophylaxis (PrEP) Care Continuum: Protocol for a Systematic Review.
    Hong C; Abrams LS; Holloway IW
    JMIR Res Protoc; 2022 Mar; 11(3):e33045. PubMed ID: 35258470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for WeExPAnd: a prospective, mixed-methods pilot demonstration study to increase access to pre-exposure prophylaxis among women vulnerable to HIV infection in the Southern USA.
    Psaros C; Goodman GR; McDonald VW; Ott C; Blyler A; Rivas A; Shan L; Campbell M; Underwood E; Krakower D; Elopre L; Kudroff K; Sherr KH; Kempf MC
    BMJ Open; 2023 Jun; 13(6):e075250. PubMed ID: 37286316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Private sector delivery of quality care for maternal, newborn and child health in low-income and middle-income countries: a mixed-methods systematic review protocol.
    Lattof SR; Maliqi B
    BMJ Open; 2020 Feb; 10(2):e033141. PubMed ID: 32071179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the study topics and characteristics of HIV pre-exposure prophylaxis research literature: a protocol for a scoping review.
    Kamitani E; Johnson AH; Wichser M; Mizuno Y; DeLuca JB; Higa DH
    BMJ Open; 2019 May; 9(5):e024212. PubMed ID: 31129574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying indicators sensitive to primary healthcare nurse practitioner practice: a review of systematic reviews protocol.
    Kilpatrick K; Tchouaket EN; Chouinard MC; Savard I; Bouabdillah N; Houle J; St-Louis G; Jabbour M; Atallah R
    BMJ Open; 2021 Jan; 11(1):e043213. PubMed ID: 33408211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of HIV treatment from the private sector in low-income and middle-income countries: a systematic review protocol.
    Mburu G; Igbinedion E; Lim SH; Paing AZ; Yi S; Elbe S; Mwai GW
    BMJ Open; 2020 Jan; 10(1):e031844. PubMed ID: 31919124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review protocol of the effectiveness of HIV prevention interventions for reducing risky sexual behaviour among youth globally.
    Mbengo F; Zgambo M; Afrifa-Yamoah E; Kalembo FW; Honda T; Shimpuku Y; Chen S
    BMJ Open; 2022 May; 12(5):e056929. PubMed ID: 35568486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Categorising implementation determinants and strategies within the US HIV implementation literature: a systematic review protocol.
    Merle JL; Li D; Keiser B; Zamantakis A; Queiroz A; Gallo CG; Villamar JA; McKay V; Zapata JP; Mustanski B; Benbow N; Smith JD
    BMJ Open; 2023 Mar; 13(3):e070216. PubMed ID: 36927593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.